ROLE OF RITUXIMAB FOR ISOLATED DE NOVO DONOR SPECIFIC ANTI-HLA ANTIBODIES IN RENAL TRANSPLANT RECIPIENTS

被引：0
|
作者：
Schafer, Antonia [1 ]
Hadaya, Karine [1 ]
Villard, Jean [1 ]
Ferrari-Lacrai, Sylvie [1 ]
机构：
[1] Geneva Univ Hosp, Geneva, Switzerland
来源：
HLA | 2020年 / 95卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
P31
引用
收藏
页码：322 / 322
页数：1
相关论文
共 50 条
  • [1] Role of rituximab for isolated de novo donor specific anti-HLA antibodies in renal transplant recipients
    Schafer, Antonia
    Ferrai-Lacraz, Sylvie
    Villard, Jean
    Hadaya, Karine
    [J]. SWISS MEDICAL WEEKLY, 2019, : 17S - 17S
  • [2] ROLE OF RITUXIMAB FOR ISOLATED DE NOVO DONOR SPECIFIC ANTI HLA ANTIBODIES IN RENAL TRANPLANT RECIPIENTS
    Schafer, Antonia
    Ferrari-Lacraz, Sylvie
    Villard, Jean
    Hadaya, Karine
    [J]. TRANSPLANT INTERNATIONAL, 2019, 32 : 418 - 418
  • [3] IMPACT OF EVEROLIMUS ON DE NOVO DONOR-SPECIFIC ANTI-HLA ANTIBODIES IN RENAL TRANSPLANT RECIPIENTS
    Kitajima, Kumiko
    Nakajima, Ichiro
    Fuchinoue, Shohei
    [J]. TRANSPLANT INTERNATIONAL, 2013, 26 : 245 - 245
  • [4] THE ROLE OF DONOR-SPECIFIC ANTI-HLA ANTIBODIES IN LIVER TRANSPLANT RECIPIENTS
    Uenlue, S.
    Lachmann, N.
    Jara, M.
    Ritschl, P. V.
    Weiss, S.
    Chopra, S.
    Denecke, C.
    Gerlach, U.
    Eurich, D.
    Pratschke, J.
    Oelinger, R.
    [J]. TRANSPLANT INTERNATIONAL, 2018, 31 : 12 - 12
  • [5] De-novo donor-specific anti-HLA antibodies in islet cell transplant recipients in Australia
    Hue, S. M.
    Torpy, D. J.
    Bennett, G.
    Kay, T. W.
    Thomas, H. E.
    Goodman, D.
    Loudovaris, T.
    O'Connell, P. J.
    Radford, T.
    Drogemuller, C. J.
    Coates, P. T.
    [J]. TRANSPLANTATION, 2016, 100 (07) : S405 - S405
  • [6] CHARACTERISTICS OF DONOR-SPECIFIC ANTI-HLA ANTIBODIES IN RENAL TRANSPLANT RECIPIENTS.
    Ghandorah, Salim
    Yilmaz, Serdar
    Abadi, Abdulnaser
    Rahmanian, Taleb
    Wang, Jinguo
    Khan, Faisal M.
    Berka, Noureddine
    [J]. HUMAN IMMUNOLOGY, 2015, 76 : 163 - 163
  • [7] The Impact of De Novo Donor Specific Anti-HLA Antibodies on the 5-Year Renal Transplant Outcome
    Banasik, M.
    Boratynska, M.
    Koscielska-Kasprzak, K.
    Zabinska, M.
    Chudoba, P.
    Patrzalek, D.
    Halon, A.
    Klinger, M.
    [J]. TRANSPLANTATION, 2012, 94 (10) : 1051 - 1051
  • [8] Risk Factors and Consequences of De Novo Anti-HLA Donor Specific Antibodies in Kidney Transplant Recipients: The Force Awakens
    Javaid, B.
    Rosen-Bronson, S.
    Li, D.
    Awwad, M.
    Gilbert, A.
    Ghasemian, S.
    Verbesey, J.
    Abrams, P.
    Grafals, M.
    Fenton, J.
    Cannon, C.
    Rapisura, J.
    Moore, J.
    Cooper, M.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 411 - 411
  • [9] When Is the Best Time to Screen for De Novo Donor Specific Anti-HLA Antibodies (DSA) in Low-Risk Renal Transplant Recipients?
    Everly, M.
    Rebellato-deVente, L. M.
    Haisch, C. E.
    Ozawa, M.
    Parker, K.
    Briley, K. P.
    Catrou, P. G.
    Bolin, P.
    Kendrick, W. T.
    Kendrick, S. A.
    Harland, R. C.
    Terasaki, P., I
    [J]. TRANSPLANTATION, 2012, 94 (10) : 1190 - 1190
  • [10] Development of De Novo Anti-HLA Antibodies in Pediatric Heart Transplant Recipients
    Chen, C. K.
    Manlhiot, C.
    Conway, J.
    Allain-Rooney, T.
    McCrindle, B. W.
    Tinckam, K.
    Dipchand, A. I.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2013, 32 (04): : S193 - S193
12345